It has been thought that adult nervous tissues show a remarkable degree of resistance to injury by x rays. Clemedson and Nelson (1960) , after a comprehensive review of the literature, state: " Nervous tissues, especially of adult animals, show a remarkable radio-resistance." In the past few years, however, experimental work on animals (Lander, 1959; Innes and Carsten, 1961) They were treated by a 4 MeV linear accelerator to an irregularly shaped field (Fig. 1) measuring approximately 15 by 5 cm., to include the scalene, supraclavicular, and axillary node areas. The field of irradiation was based on the axillary-subclavian venogram, as described by Ackland, Holman, and Stoll (1960) . The peak dose delivered to an anteriorly placed field was at two dose levels-6,300 rads in 12 increments in 25 to 26 days in 33 cases, and 5,775 rads in 11 or 12 increments in 25 to 28 days in 84 cases. Fig. 2 (Fig. 3) .
It has been thought that adult nervous tissues show a remarkable degree of resistance to injury by x rays. Clemedson and Nelson (1960) , after a comprehensive review of the literature, state: " Nervous tissues, especially of adult animals, show a remarkable radio-resistance." In the past few years, however, experimental work on animals (Lander, 1959; Innes and Carsten, 1961) suggests that delayed degeneration of spinal nerves can follow doses of x rays which are near the clinical range. Clinically, also, peripheral nerves have in the past been regarded as relatively radio-resistant. Damage to nerves from the high dose in the vicinity of radium needles was, of course, a well-recognized complication of the Keynes technique for radium implantation of the axillary contents. However, with the use of kilovoltage x-ray therapy in the past, the skin tolerance was the limiting factor in dosage, and damage to peripheral nerves was rarely seen. More recently, however, with the development of megavoltage x-ray machines, peak dosage is below the skin and the risk of nerve damage is therefore increased. This report presents evidence of peripheral-nerve damage in a group of patients treated by megavoltage x-ray therapy after operation for carcinoma of the breast.
Patient Material and Radiation Technique
The 117 female patients surveyed were a con- secutive series treated during by an identical far1xill mammar technique. Megavoltage x-ray therapy was given within a period of 3 to 10 weeks after radical mastectomy. Of the patients, 65 % were aged 50 or less, and 70% had demonstrable metastases in the axillary nodes at operation.
They were treated by a 4 MeV linear accelerator to an irregularly shaped field ( Fig. 1 ) measuring approximately 15 by 5 cm., to include the scalene, supraclavicular, and axillary node areas. The field of irradiation was based on the axillary-subclavian venogram, as described by Ackland, Holman, and Stoll (1960) . The peak dose delivered to an anteriorly placed field was at two dose levels-6,300 rads in 12 increments in 25 to 26 days in 33 cases, and 5,775 rads in 11 or 12 increments in 25 to 28 days in 84 cases. Fig. 2 (Fig. 3) .
The incidence of neuropathy is expressed as a proportion of the total number of treated patients followed for a period of up to 30 months. However, it is realized that a proportion of patients who died within this period without developing symptoms might well have shown them had they survived. In the group receiving 6,300 rads neurological symptoms were complained of by 24 out of 33 patients (73%). In the group receiving 5,775 rads neurological symptoms were complained of by 13 out of 84 patients (15%). It is interesting to note (Fig. 3) 
Dose-time Considerations
In this series it should be noted that there were two different dose levels of radiation reported. If it be assumed that the affected portion of the brachial plexus lies at a depth of 2-4 cm. the higher dose of 6,300 rads peak delivers a minimum dose of 5,500 rads at the plexus. The lower dose of 5,775 rads peak delivers a minimum dose of 5,100 rads at the same depth. Both doses were given in 11 or 12 increments in 25 to 28 days. The incidence of neuropathy was 73% with the higher dose and 15 % with the lower dose.
Information on the relationship between dose level and the incidence of neuropathy is available from two other series also. First, a group of 25 patients were treated by 4 MeV x rays to a large supraclavicular field (up to 22 by 13 cm.) to a peak dose of 4,650 to 5,550 rads in 18 to 20 days. With this dose level neuropathic symptoms were noted in 16% of patients. Assuming that the affected portion of the brachial plexus lies at a depth of 2-4 cm., then the minimum dose associated with neuropathy in this group was 4,100 in nine increments in 18 days.
Secondly, a group of 139 patients were treated by orthovoltage (200 kV, H.V.L. 1 mm. Cu) with small fields (4 by 6 cm.) to the apical axilla with a tumour dose of 4,300 to 5,300 rads in 25 to 28 days. In this series neuropathic symptoms were noted in 10% of cases. The minimum dose associated with neuropathy in this group was 4,350 rads in 10 increments in 25 days.
It is thus seen that an incidence of neuropathy on 10-20% of cases is noted for three dose levels-that is, minimum, 5,100 rads in four weeks with 4 MeV x rays; minimum, 4,100 rads in three weeks with 4 MeV x rays; minimum, 4,350 rads in four weeks with 200 kV x rays. In all groups increments of 400-500 rads were given three times weekly.
These dosage levels and increments lead to a substantial risk of delayed neuropathic symptoms even if minimal in the majority. It is also worthy of note that we have recorded similar symptoms occasionally even after quite modest radiation doses of the order of 3,500 to 3,700 rads in 20 increments in 25 to 27 days given by 200 kV x rays.
Limited data are available concerning the morphological changes which follow irradiation of the peripheral nerves of adult animals. For many years Janzen and Warren (1942) were quoted as reporting the absence of functional or structural changes in the sciatic nerve of the rat up to two months after doses of 4,000 to 10,000 r of 200 kV x rays. However, Linder (1959) irradiated the rat sciatic nerve to a dose of 3,000 r in five days and found focal nerve degeneration and scarring in BRMSH JOURNAL 25 % of cases when examined 3 to 11 months after irradiation. A later paper (Innes and Carsten, 1961) reports irradiation of the nerves of the cauda equina of rats with a dose of 3,500 rads (presumably as a single dose). After about seven months all the rats showed severe degenerative lesions of the spinal nerves. It is therefore suggested that the observations of Janzen and Warren were not sufficiently extended after irradiation to note a degenerative effect similar to that found by the later authors. When the latent period between radiation and first neurological symptoms is plotted in our cases (Fig. 3) it is interesting to note that the majority incidence is between 10 and 22 months.
Functional changes, however, appear in experimentally irradiated nerve at lower dose levels than do structural changes. Arnold et al. (1961) reports depressed conduction in the saphenous nerve of the cat soon after such moderate doses as 1,000 to 3,000 r of 250 kV x rays.
Relationship of Neuropathology to Other Causes
Moderate-to-severe oedema of the arm was noted in 40 out of the 117 patients (19 out of 33 patients receiving the higher dose ; 21 out of 84 receiving the lower dose). This incidence is higher than that resulting from our previous technique, which delivers a tumour dose of 3,800 rads in 28 days by kilovoltage to the axilla and supraclavicular area.
The higher incidence of oedema undoubtedly reflects the greater degree of fibrosis resulting from the high-dose megavoltage technique.
A common clinical finding was gross induration in the supraclavicular fossa, and in some cases forceful pressure on this area caused a painful sensation to radiate into the fingers.
Though the degree of clinical oedema was not often related to the degree of neuropathy, the possibility of relationship has been considered for several reasons. (1) According to Treves (1957) , in an analysis of over 1,000 post-mastectomy cases the onset of oedema was at 11 to 23 months after mastectomy. This is remarkably similar to the peak incidence of postirradiation neuritis in our series (10 to 22 months). (2) Several patients volunteered the information that their neurological symptoms improved when the oedema was reduced (by corticosteroid, diuretic, or pressure-cuff therapy).
Decompressive measures seem to have improved the symptoms in some cases. Three patients with predominantly median-nerve symptoms were greatly relieved after decompression of the carpal tunnel. In addition, two patients complaining of severe sensory symptoms were investigated by exposure of the brachial plexus above the clavicle. They derived some relief of symptoms from this procedure, though motor and sensory changes persisted.
These observations suggest that pressure on peripheral nerves by oedema may be an additional factor but not the basic cause of the neuropathy. The importance of oedema at the " entrapment points " along the course of the nerve in causing brachial neuropathy has been stressed (Thompson and Kopell, 1959) .
It should be emphasized that in all these cases radiation was given to tissues recently subjected to radical surgery; the role of infections and sloughing in causing oedema and fibrosis must be accepted.
The diagnosis of radiation damage to the brachial plexus is made difficult by the differential diagnoses of cervical spondylosis (which is a common finding in this age group), pressure from metastatic supraclavicular nodes, and the carpaltunnel syndrome. As noted previously, three cases had a carpaltunnel decompression in this series.
Summary
Peripheral-nerve damage is reported in a series of patients treated post-operatively for breast carcinoma by a small-field, high-dose megavoltage x-ray technique. The clinical nature of the damage has been assessed and an attempt made to establish the site of damage.
Of the patients receiving 6,300 rads peak dose in 25 to 26 days neurological symptoms were complained of by 73%, and of the group receiving 5,775 rads peak dose by 15%. In the higher-dose group the majority of patients with symptoms had abnormal neurological signs.
Pathological data in two cases are given and mention is made of factors other than radiation which may have contributed to the nerve damage noted. It is concluded that high-dose, smallfield megavoltage irradiation following radical surgery leads to delayed damage to the brachial plexus, the incidence being related to the level of dosage. Our past experience with other techniques has been analysed for purposes of comparison.
We wish to thank Dr. P. Bladin, of St. Vincent's Hospital, Melbourne, for his co-operation in the electromyographic studies mentioned, and Dr. W. P. Holman, Medical Director, for his constant interest in the clarification of this problem.
Amoebiasis is a disease of world-wide distribution but is particularly prevalent in tropical countries such as India. The condition may be manifested by intestinal or extra-intestinal symptoms. In intestinal amoebiasis the basis on which diagnosis is made is the presence of Entamoeba histolytica in the stools. In extra-intestinal amoebiasis difficulties are encountered in making a definite diagnosis, since the stools show E. histolytica in only a small percentage of cases. The decision in such cases is based on the clinical picture, haematological examination, and radiological signs. The need for a reliable laboratory test has long been felt.
Craig (1927, 1929, 1930, 1933, 1937) and Craig and Scott (1935) recognized the value of the complement-fixation test in the diagnosis of amoebiasis. Since then a number of reports have been published (Meleney and Frye, 1937 ; Rees et al., 1942 ; Ghosh et al., 1948 ; Terry and Bozicevich, 1948 ; Hussey and Brown, 1950; Dolkart et al., 1951 ; McDearman and Dunham, 1952) . There has been wide variation in the observations made by various workers, mainly because of the different types of antigen used and the techniques employed. Furthermore, the reliability of a complement-fixation test for amoebiasis in hyperendemic areas, where it is needed most, has often been questioned because of strong anamnestic reactions resulting from repeated infection with E. histolytica.
Present Investigations
This study was undertaken to evaluate the significance of the complement-fixation test in both intestinal and hepatic amoebiasis in India by means of an antigen which had proved to be a reliable diagnostic tool in New York. Material and Methods.-Complement-fixation tests for amoebiasis were carried out on cases of chronic intestinal amoebiasis, hepatic amoebiasis, and controls, including normal individuals and patients with conditions other than amoebiasis.
The diagnosis of amoebic hepatitis was made on the finding of an enlarged tender liver, together with a history of blood and mucus in-the stools, and either positive stool culture for E. histolytica or sigmoidoscopic evidence of typical amoebic ulcers.
All the cases were evaluated by a detailed clinical history, a complete physical examination, laboratory measures, including liver-function tests, and repeated stool examination. The complement-fixation test was performed with the Micro-Kolmer technique as described by Kenney (1952) . The antigen was prepared by the New York Group, using the method described by Kenney (1952) , and shipped to India in a lyophilized state.
Results
Among 45 cases of intestinal amoebiasis the complementfixation test was positive in only 7 (15.5%) cases (Table I ). All of them had E. histolytica cysts in the stools. One patient harboured E. histolytica trophozoites in addition, and a 
